Benjamin Stone
Patrimonio netto: 275 502 $ in data 31/05/2026
Patrimonio netto: 275 502 $ in data 31/05/2026
Benjamin Stone is the founder of IconOVir Bio, Inc.,76Bio, Inc. Mr. Stone currently holds the position of Chief Business Officer at AnaptysBio, Inc. since 2022.
Mr. Stone also serves as Chief Business Officer at First Tracks Biotherapeutics, Inc. Mr. Stone completed undergraduate education at the University of Pennsylvania and The Wharton School of the University of Pennsylvania.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
0,05% | 12/05/2026 | 17.262 ( 0,05% ) | 275 502 $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| ANAPTYSBIO, INC. | Corporate Officer/Principal | 01/01/2022 |
| Società | Posizione | Fine |
|---|---|---|
IconOVir Bio, Inc.
IconOVir Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which develops oncolytic virus therapy to improve the treatment of patients with cancer | Fondatore | - |
76bio, Inc.
76bio, Inc. Pharmaceuticals: MajorHealth Technology Develops transformational therapies for patients with life-threatening disease | Fondatore | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 5 |
|---|---|
AnaptysBio, Inc.
AnaptysBio, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company | Health Technology |
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Wharton School of the University of Pennsylvania
The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
IconOVir Bio, Inc.
IconOVir Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which develops oncolytic virus therapy to improve the treatment of patients with cancer | Health Technology |
76bio, Inc.
76bio, Inc. Pharmaceuticals: MajorHealth Technology Develops transformational therapies for patients with life-threatening disease | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale